NCIt definition : A humanized monoclonal antibody against interleukin 13 (IL-13) with immunosuppressive
and anti-asthmatic activities. Lebrikizumab binds to IL-13 and inhibits IL-13-mediated
pathways. IL-13, a cytokine mainly secreted by type 2 helper T cells, plays a key
role in the induction of allergic inflammation.;
UNII : U9JLP7V031;
CAS number : 953400-68-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 953400-68-5
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;